Veracyte, Inc. (VCYT) Covered Calls

Veracyte Inc is engaged in the discovery, development and commercialization of molecular cytology solutions that enable physicians to make more informed treatment decisions at an early stage in patient treatment.

You can sell covered calls on Veracyte, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for VCYT (prices last updated Mon 9:35 AM ET):

Veracyte, Inc. (VCYT) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
36.13	+0.19	35.98	36.13	13K	-	2.8

Covered Calls For Veracyte, Inc. (VCYT)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Dec 20	35	1.50	34.63	1.1%	12.2%
Jan 17	35	2.50	33.63	4.1%	24.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

Veracyte, Inc. is a molecular diagnostics company. The company discovers, develops and commercializes molecular diagnostic solutions that enable physicians to make more informed treatment decisions early. Its first commercial solution is Afirma Thyroid FNA Analysis, which specializes in cytopathology assessment with the afirma gene expression classifier, a genomic test that clarifies inconclusive thyroid nodule results as benign or suspicious for cancer. The company was founded by Bonnie H. Anderson and Doug Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Top 10 Open Interest For Dec 20 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	QQQ covered calls	1.	SAVA covered calls
2.	SPY covered calls	7.	XLF covered calls	2.	NMRA covered calls
3.	EEM covered calls	8.	KWEB covered calls	3.	CRVS covered calls
4.	FXI covered calls	9.	TLT covered calls	4.	MARA covered calls
5.	IWM covered calls	10.	KRE covered calls	5.	CLSK covered calls

Want more examples? VCTR Covered Calls | VDC Covered Calls